Olivier joined the Board and was appointed Chief Executive Officer in April 2011. Prior to joining Smith & Nephew from Pierre Fabre, where he was Chief Executive, he was the Executive Vice President at Abbott Laboratories with responsibility for the Pharmaceuticals division. He held a series of international roles at Abbott, who he joined in 2003, and was based in a number of locations, most recently in Chicago. Prior to Abbott he held a number of roles with GlaxoSmithKline ultimately as Senior Vice president for European Commercial Operations – Pharmaceuticals. Olivier holds a doctorate from the University of Paris and an MBA from HEC. PDMR. CommOps. CES.

Adrian joined the Group and was appointed a director in June 2006. He was previously Chief Financial Officer of Invensys plc and held various senior positions within GlaxoSmithKline. Adrian is a member of the Supervisory Board of Reed Elsevier NV and a non-executive director of Reed Elsevier PLC. PDMR. CommOps. CES.

Jeff joined the Group in February 2008 as Sr. Vice President of Global Operations.  Prior to joining Smith and Nephew, Jeff held progressively senior leadership roles in Operations, Sourcing and Supply Chain Management at Danaher and General Electric. During his career, Jeff has been involved in the implementation of multiple, world-class operational tools including lean manufacturing and six sigma. CommOps.

Mark joined the Group in 2003 as Vice President of Global Marketing for the Trauma Division, becoming President Orthopaedic Trauma and Clinical Therapies in February 2006. He became President of Biologics on the formation of the new GBU in January 2008. He previously worked for GE Medical Systems in the US and Asia. PDMR. CommOps. CES.

Jack Campo joined the Group in June 2008 from the GE Equity division of General Electric Company, where he was a Senior Managing Director and General Counsel.  During his time with GE, he spent 5 years in Hong Kong with GE Healthcare (successor to GE Medical Systems), as well as time in Transactions with Healthcare in their Milwaukee headquarters and at GE Corporate in Fairfield, Connecticut.

Prior to GE, he worked with Biogen, Inc. and Bank of New England Corporation. Before he moved into public companies, Jack worked with Davis Polk & Wardwell in New York and Paris. PDMR. CES.

Francisco joined Smith & Nephew in January 2012 as President of Emerging Markets, which encompasses the Group’s operations in China, India, Brazil and Russia. During his career he has held senior management roles in global companies including Gambro AM, Excelsior and Baxter International. Francisco has lived and worked in several countries including China, Japan, the US and Spain and is a former Board member of EUCOMED. PDMR. CommOps. CES.

Phil is Smith & Nephew’s Head of Corporate Affairs and responsible for all external Group communications, including Investor Relations and media. He joined in 2008. Prior to joining Smith & Nephew, Phil was a senior Director at Deutsche Bank where he spent 13 years providing corporate finance and Equity Capital Markets advice to a wide range of UK corporates. He is a qualified chartered accountant. CES.

Michael joined the Group in July 2006 as President of our Endoscopy business. Since July 2011 he has headed up our Advanced Surgical Devices Division. Previously he was President and Chief Executive Officer of a US manufacturer of medical devices and spent 15 years at Tyco Healthcare becoming President of each of Patient Care and Health Systems divisions. PDMR. CommOps. CES.

Susan Henderson, MA, FCIS has had 25 years experience as a company secretary in a wide range of businesses covering Board support, corporate governance, corporate transactions, corporate social responsibility, pensions, insurance and employee and executive share plans. She joined Smith & Nephew in May 2009 as Company Secretary. She has previously held various company secretarial positions at Prudential, RMC and Amersham, where she was Deputy Secretary for 5 years prior to its takeover by GE in 2004. CES.

Gordon joined the Group in May 1998 in Finance and has served in planning and business development roles in the Orthopaedic GBU. He was appointed to his current role in August 2007. Prior to joining the Group, he held management positions with United Technologies Corporation. PDMR. CommOps. CES.

The President of International Markets, Kelvin Johnson, has been with Smith & Nephew for more than 20 years. A South African, with qualifications in Economics, Industrial Psychology, Labour Economics and Business Administration, his experience covers Manufacturing, HR, Business Development, Selling and Marketing.

Prior to Smith & Nephew he worked in the Automotive Industry, for the Ford Motor Company. PDMR. CommOps. CES.

Helen joined the Group in July 2011 as Senior Vice President of Human Resources. Helen brings more than 30 years of experience across a variety of international and global HR and operational roles in both medical devices and pharmaceuticals. Most recently, Helen was Divisional Vice President of Human Resources for the Pharmaceuticals Group of Abbotts Laboratories. PDMR. CommOps. CES.

Arjun joined the Group as Chief Compliance Officer in February 2009 from GlaxoSmithKline, where he had worked for 14 years in a variety of compliance roles, most recently serving as Vice President & Compliance Officer, US Pharmaceuticals. Prior to this he worked at Sidley Austin. Arjun is a founding member and co-chair of the industry-wide Pharmaceutical Compliance Forum. CES.

Ros joined the Group in November 2011 as Chief Technology Officer, responsible for the Group’s manufacturing operations, IT systems, Corporate Sustainability and Regulatory and Quality Affairs. She brings more than 30 years of global experience across all aspects of operational excellence. Ros has held progressively senior roles ranging from sales and marketing through supply chain and distribution at global companies, including Imperial Chemical Industries, Tate & Lyle, Diageo and Premier Foods. PDMR. CommOps. CES.

Roger Teasdale joined Smith & Nephew in 1989 and during that time has held positions in Finance, Business Development and Operations. For six years Roger was Managing Director of the Extruded Films business and most recently he was the Senior Vice President of the Advanced Woundcare SBU, serving at the same time as President North America on an interim basis for nearly a year. He was appointed President of the Advanced Wound Management in May 2009. Roger has vast experience in the areas of Finance, Marketing, Business Development, R & D, Operations, Sales and executive leadership experience. He previously worked for Fenner Dunlop a publicly traded Engineering Company. PDMR. Comm Ops. CES.